-
Ambu Appoints Kellee Fitzsimmons as Tax Director
Post on 7/20/20
-
Is Novavax Stock a Buy?
Post on 7/20/20
-
Better Buy: Novavax vs. Roche
Post on 7/20/20
-
Ambu Receives FDA Clearance for its Sterile, Single-use Duodenoscope
Post on 7/17/20
-
Why Novavax Stock Jumped Today
Post on 7/17/20
-
Altimmune Closes $132M Public Offering
Post on 7/16/20
-
Is Novavax Still a Good Coronavirus Stock to Buy?
Post on 7/16/20
-
3 Reasons to Buy Novavax Stock Sooner Rather Than Later
Post on 7/16/20
-
Virginia Mason Health System Partners with Premier
Post on 7/15/20
-
I-Mab Announces Authorization of Stock Repurchase Program up to $20M
Post on 7/15/20
-
Rite Aid Expands COVID-19 Testing to 258 Total Locations
Post on 7/15/20
-
Altimmune Prices Public Offering of $115 Million of Common Stock
Post on 7/14/20
-
IPO Update: ACell Proposes $75 Million IPO Terms
Post on 7/14/20
-
Altimmune Proposes Public Offering of Common Stock and Pre-Funded Warrants
Post on 7/13/20
-
Ellicott City ER Doctor Introduces A New Device That Protects Healthcare Workers While Intubating Covid-19 Patients
Post on 7/13/20
-
Evolent Health Named on Best Companies for Women to Advance List 2020 by Parity.org
Post on 7/13/20
-
ACell Launches Roadshow for Initial Public Offering
Post on 7/13/20
-
Cellular Biomedicine Group (CBMG) Hosts R&D Showcase and Provides Updates to Clinical Programs
Post on 7/13/20
-
Menarini Silicon Biosystems Partners with OpGen
Post on 7/13/20
-
Is It Too Late to Buy Novavax Stock?
Post on 7/13/20
-
Altimmune Signs Teaming Agreement with DynPort Vaccine Company
Post on 7/12/20
-
National Institutes of Health Federal Credit Union Announces Expanded Charter
Post on 7/9/20
-
UnitedHealthcare Donates $250,000 to Nonprofits Serving Charleston, West Virginia
Post on 7/9/20
-
Why Novavax Is Outperforming Moderna
Post on 7/8/20
-
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
Post on 7/8/20
Washington DC
